Life Technologies Buying BioTrove
Life Technologies Corp. (Nasdaq: LIFE) has agreed to acquire BioTrove Inc., a Woburn, Mass.-based maker of instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics. No financial terms were disclosed. As part of the transaction BioTrove will spin out its RapidFire mass spectrometry system into an independent company supported by existing investors. BioTrove late last year withdrew registration for a $75 million IPO, after having raised over $43 million in VC funding from firms like Catalyst Health & Technology Partners, CB Health Ventures, Vox Equity Partners, Biofrontier Partners, Fletcher Spaght Associates and Pfizer.
11 November 2009•4 mins read
